Mayumi Kinoshita

Mayumi Kinoshita

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KTKazuhiro Tamura
Kazuhiro Tamura
YTYoshinobu Tomita
Yoshinobu Tomita
タ金タクミ 金沢
タクミ 金沢
HSHajime Shinohara
Hajime Shinohara
MSMasayoshi Sakano
Masayoshi Sakano
KYKouhei Yamamoto
Kouhei Yamamoto
Gastric cancer is one of the most common cancers worldwide, and new therapeutic strategies are urgently needed. Ferroptosis is an intracellular iron-dependent cell death induced by the accumulation of lipid peroxidation, a mechanism different from conventional apoptosis and necrosis. Therefore, induction of ferroptosis is expected to be a new therapeutic strategy. Glutathione peroxidase 4 (GPX4) and ferroptosis suppressor protein 1 (FSP1) have been identified as the major inhibitors of ferroptosis. Herein, we performed immunohistochemistry for GPX4, FSP1, and 4-HNE using tissues from patients with gastric cancer and investigated the relationship between these factors and prognosis. Patients with high GPX4 expression or high GPX4 expression and low 4-HNE accumulation tended to have a poor prognosis (p = 0.036, 0.023), whereas those with low FSP1 expression and high 4-HNE accumulation had a good prognosis (p = 0.033). The synergistic induction of cell death by inhibiting GPX4 and FSP1 in vitro was also observed, indicating that the cell death was non-apoptotic. Our results indicate that the expression and accumulation of lipid peroxidation-related factors play an important role in the clinicopathological significance of gastric cancer and that novel therapeutic strategies targeting GPX4 and FSP1 may be effective in treating patients with gastric cancer who have poor prognosis.

20 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
HTHirotomo Takahara
Hirotomo Takahara
タ金タクミ 金沢
タクミ 金沢
HOHaruna Oshita
Haruna Oshita
YTYoshinobu Tomita
Yoshinobu Tomita
YHYuri Hananoi
Yuri Hananoi
KYKouhei Yamamoto
Kouhei Yamamoto
Background: Primary lung cancer is among the cancers with the poorest prognosis, having the highest mortality rate among men and the second highest among women in Japan. While surgery is the primary treatment, advanced stages often require pharmacotherapy. Recently, ferroptosis, an iron-dependent form of cell death caused by lipid peroxidation, has gained attention as a potential therapeutic strategy. This study investigated the prognostic impact of lipid peroxidation marker and regulators involved in ferroptosis in lung adenocarcinoma. Methods: We analyzed 207 patients who underwent resection surgery for lung adenocarcinoma at Tokyo Medical and Dental University Hospital. Immunohistochemistry was used to evaluate the expression levels of glutathione peroxidase 4 (GPX4), ferroptosis suppressor protein 1 (FSP1), and 4-hydroxy-2-nonenal (4-HNE). The association between these markers and clinicopathological factors was assessed, and in vitro experiments were conducted to examine the effects of these markers on cell death. Results: Low cytoplasmic accumulation of 4-HNE and low expression of GPX4 were associated with a worse prognosis, and low FSP1 expression was associated with unfavorable relapse-free survival. In vitro experiments demonstrated that 4-HNE inhibited cell proliferation, and combined inhibition of GPX4 and FSP1 induced ferroptosis. Conclusions: These findings suggest that lipid peroxidation markers and regulators can serve as prognostic biomarkers and therapeutic targets in lung adenocarcinoma.

12 December 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
MKMayumi Kinoshita
Mayumi Kinoshita
MSMotoji Sawabe
Motoji Sawabe
YSYurie Soejima
Yurie Soejima
MMMakiko Mieno
Makiko Mieno
TATomio Arai
Tomio Arai
NHNaoko Honma
Naoko Honma
The predominant histological subtype of breast mucinous carcinoma in older women is type B (hypercellular type), and, in younger women, it is type A (hypocellular type). The characteristics of mucinous carcinomas of the same histological subtype may differ between older and younger women. This study aims to systematically clarify the pathological/immunohistochemical features of mucinous carcinomas. A total of 21 surgical cases of mucinous carcinoma (type A/B: 9/12 cases) in the older group (≥65 years) and 16 cases (type A/B: 14/2 cases) in the younger group (≤55 years) (n = 37) were included. Gross cystic disease fluid protein-15 (GCDFP-15) and eight other markers were used for immunostaining. The GCDFP-15-positive rate in the older group was high regardless of the histological subtype (type A, 77.8%; type B, 91.7%). The GCDFP-15 positivity in the older group was significantly higher than that in the younger group (p < 0.001 for Allred score). Among type A, GCDFP-15 positivity was significantly higher in the older group than in the younger group (p = 0.042 for the Allred score and p = 0.007 for the positivity rate). The present results suggest that GCDFP-15 expression characterizes mucinous carcinomas in older women.

1 April 2017 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
Shinnosuke HadaShinnosuke Hada
Shinnosuke Hada
MIMuneaki Ishijima
Muneaki Ishijima
HKH. Kaneko
H. Kaneko
LLL. Lizu
L. Lizu
MKMayumi Kinoshita
Mayumi Kinoshita
KKK. Kaneko
K. Kaneko


1 September 2009 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
SOShuhei Otsuki
Shuhei Otsuki
SMShigeru Miyaki
Shigeru Miyaki
SGS.P. Grogan
S.P. Grogan
HAHiroshi Asahara
Hiroshi Asahara
MKMayumi Kinoshita
Mayumi Kinoshita
MLM.K. Lotz
M.K. Lotz